GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,401.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,074.85m
  • Volume: 363,107
  • Market Cap: £57,109m
  • RiskGrade: 129

Latest ShareCast News

GSK gepotidacin edges closer to landmark approval for gonorrhoea

By Iain Gilbert

Date: Monday 11 Aug 2025

(Sharecast News) - Drugmaker GSK moved closer to expanding its antibiotic portfolio on Monday, after US regulators accepted its application to review gepotidacin as a potential oral treatment for gonorrhoea.

GSK ShareCast News

GSK and CureVac secure $740m payout in mRNA pate... 08-Aug-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast

GSK Regulatory News

Transaction in Own Shares 12-Aug-2025 07:00 RNS
FDA to review gonorrhea indication for gepotidacin 11-Aug-2025 07:00 RNS
Transaction in Own Shares 11-Aug-2025 07:00 RNS
CureVac/BioNTech mRNA patent litigation settlement 08-Aug-2025 07:00 RNS
Transaction in Own Shares 08-Aug-2025 07:00 RNS

GSK Newspaper Links

GSK profits lifted by strong cancer drug sales 30-Jul-2025 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,401.50p
Change Today -2.50p
% Change -0.18 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 363,107
Shares Issued 4,074.85m
Market Cap £57,109m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
22.63% below the market average22.63% below the market average22.63% below the market average22.63% below the market average22.63% below the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 12-Aug-2025

Time Volume / Share Price
09:28 4 @ 1,401.50p
09:28 4 @ 1,401.00p
09:28 271 @ 1,401.50p
09:28 83 @ 1,401.50p
09:28 0 @ 1,401.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page